Post-hoc analysis of the CARES trial suggests delayed progression of #chronickidneydisease in patients with #gout during urate-lowering therapy

doi.org/10.1016/j.kint.2024.10.022

#NephSky #MedSky #CKD #allopurinol #febuxostat